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Abstract 29 
 30 
Introduction: During the first trimester of human pregnancy, fetally-derived extravillous trophoblast 31 
(EVT) cells invade into uterine decidua and remodel the uterine spiral arteries to ensure that 32 
sufficient blood reaches the maternal-fetal interface. Decidual macrophages have been implicated in 33 
the regulation of decidual remodelling and aberrant activation of these immune cells is associated 34 
with pre-eclampsia. 35 
Methods: The monocytic cell line THP-1 was activated to induce an M1 or M2 phenotype and the 36 
conditioned media was used to treat the EVT cell line SGHPL-4 in order to determine the effect of 37 
macrophage polarisation on trophoblast behaviour in-vitro. SGHPL-4 cell functions were assessed 38 
using time-lapse microscopy, endothelial-like tube formation assays and western blot. 39 
Results: The polarisation state of the THP-1 cells was found to differentially alter the behaviour of 40 
trophoblast cells in-vitro with pro-inflammatory M1 conditioned media significantly inhibiting 41 
trophoblast motility, impeding trophoblast tube formation, and inducing trophoblast expression of 42 
caspase 3, when compared to anti-inflammatory M2 conditioned media.  43 
Discussion: Macrophages can regulate trophoblast functions that are critical during decidual 44 
remodelling in early pregnancy. Importantly, there is differential regulation of trophoblast function 45 
in response to the polarisation state of these cells.  Our studies indicate that the balance between a 46 
pro- and anti-inflammatory environment is important in regulating the cellular interactions at the 47 
maternal-fetal interface and that disturbances in this balance likely contribute to pregnancy 48 
disorders associated with poor trophoblast invasion and vessel remodelling. 49 
 50 
 51 
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INTRODUCTION 1 
 2 
Human pregnancy represents a unique immunological paradigm; requiring tolerance of the semi-3 
allogeneic fetus, regulation of placentation, and maintenance of host-defence against pathogens. 4 
During the first trimester of pregnancy, the uterine decidua changes significantly as fetally-derived 5 
extravillous trophoblast (EVT) cells invade and remodel the uterine spiral arteries, ensuring a 6 
sufficient blood supply to facilitate the transfer of nutrients across the maternal-fetal interface (1). 7 
Pre-eclampsia is a complication of pregnancy typically characterised by gestational hypertension and 8 
proteinuria, and clinically diagnosed after the 20th week of gestation (2). Pre-eclampsia is estimated 9 
to affect 2-8% of pregnant women worldwide and is a leading cause of maternal and fetal morbidity 10 
and mortality (3). Although the pathophysiology of pre-eclampsia is yet to be fully elucidated, 11 
inadequate spiral artery remodelling and shallow trophoblast invasion during the first trimester are 12 
associated with the condition (4-6).  13 
 14 
Macrophages are large mononuclear phagocytic cells that predominantly function to clear 15 
extraneous cellular material from the interstitial environment but also have a central role in innate 16 
and adaptive immunity (7). Given the array of macrophage functions, considerable macrophage 17 
diversity and plasticity exists (8). The extremes of activation state are represented by classically 18 
activated (CA) macrophages which act as effector cells in immune responses, and alternatively 19 
activated (AA) macrophages which are involved in immunosuppression and wound healing/tissue 20 
repair. However, specific differentiation depends on the local tissue environment, with evidence that 21 
macrophages can switch between activation states when exposed to pro- or anti-inflammatory 22 
cytokines (9).  23 
 24 
During the first-trimester of pregnancy, approximately 40% of all decidual cells are leukocytes, of 25 
which 70% are decidual natural killer cells and 20-30% are decidual macrophages (10, 11). 26 
Histological studies have shown that the population of decidual macrophages remains relatively 27 
stable throughout pregnancy as opposed to the population of decidual natural killer cells, which 28 
declines as pregnancy progresses (11). Furthermore, decidual macrophages are found in abundance 29 
at the site of implantation, clustered around spiral arteries and in close proximity to invading EVT 30 
(12-14), suggestive of an important role at the maternal-fetal interface.  31 
 32 
Decidual macrophages have not been extensively characterised though microarray studies have 33 
shown that they have a unique phenotype with expression of genes associated with both classical 34 
and alternative activation. When compared to peripheral blood monocytes, the majority of 35 
upregulated genes are found to be implicated in immune modulation and tissue remodelling, 36 
reflecting the phenotype of an AA macrophages (15). DNA methylation profiling of decidual 37 
macrophages has demonstrated hypermethylation of genes encoding classical markers of 38 
macrophage activation and hypermethylation of genes encoding alternative activation (16).  39 
 40 
However, decidual macrophages also express some genes associated with immune activation, and 41 
secrete pro-inflammatory cytokines such as TNF-alpha, in addition to potent anti-inflammatory 42 
cytokines such as IL-10 (17, 18). Recent studies have suggested that there may be sub-sets of 43 
decidual macrophages characterised by CD11c expression, with a high CD11c expression associated 44 
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with lipid metabolism and inflammation, and low CD11c expression associated with extracellular 45 
matrix formation, muscle homeostasis, and tissue development (19). ICAM-3 expression has also 46 
been correlated with the CD11c expressing sub-populations (20). The expression of genes associated 47 
with alternative activation in addition to some genes associated with immune activation likely 48 
reflects the need for a tolerogeneic environment to support successful pregnancy while maintaining 49 
the potential for an effective inflammatory response against pathogens. 50 
 51 
Aberrant decidual macrophage activation towards a more CA phenotype has previously been 52 
associated with the pathology of pre-eclampsia. Term decidua from pre-eclamptic pregnancies has 53 
significantly more pro-inflammatory CD86+ macrophages when compared with normal pregnancies 54 
(21). In addition, a study of first trimester decidual tissue from chorionic villus sampling found a 55 
lower ratio of regulatory CD206/CD86+ macrophages in the decidua of women who subsequently 56 
developed pre-eclampsia compared to those with a normal pregnancy outcome. Moreover, there is 57 
an increase in decidual macrophage mRNA expression of the pro-inflammatory cytokine IL-6 prior to 58 
clinical signs of pre-eclampsia (22), and excess TNF-α production has been postulated to inhibit 59 
normal EVT invasion in pre-eclampsia (23). 60 
 61 
The aim of our study was to model the effects of differential macrophage polarisation on 62 
trophoblast behaviour. The human acute monocytic leukemia cell line (THP-1) can be polarised to 63 
generate macrophage phenotypes at the extreme ends of the polarisation spectrum and were used 64 
to generate CA and AA macrophage-like cells. The effect of factors secreted by these cells on a 65 
trophoblast cell line was analysed with respect to the motility, proliferation, apoptosis, and 66 
formation of network structures. 67 
 68 
 69 
MATERIALS AND METHODS 70 
Macrophage Differentiation 71 
THP-1 cells were differentiated into macrophage-like cells by adapting a previously described 72 
method (24). Briefly, cells were treated with 100nM of phorbol 12-myristate 13-acetate (Sigma-73 
Aldrich, Dorset, UK) in phenol red free Roswell Park Memorial Institute (RPMI) 1640 medium 74 
(Invitrogen, Paisley, UK) supplemented with 10% (v/v) fetal bovine serum (FBS), containing 2mmol/L 75 
L-glutamine, 100 IU/mL penicillin, 100mg/mL streptomycin and 2.5µg/mL amphotericin B (THP-1 76 
medium). After 6h 100ng/mL of lipopolysaccharide (LPS) and 20ng/mL of IFN-γ or 20ng/mL of IL-4 77 
(PeproTech, Rocky Hill, NJ) and 20ng/mL of IL-13 (PeproTech) was added to generate an CA or AA 78 
phenotype, respectively. The cells were cultured in the polarising media for 3 days and washed 79 
thoroughly three times with PBS. The cells were then treated with fresh THP-1 medium containing 80 
10% (v/v) FBS or no serum. The conditioned media (CM) was collected after 24h, centrifuged to 81 
remove cellular debris, and stored at -80°C until used.   82 
 83 
 84 
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Characterisation of Macrophage Polarisation 85 
To assess polarisation, the pro-inflammatory cytokines TNF-α and IL-6 (CA markers), or the anti-86 
inflammatory cytokine transforming growth factor beta (TGF-β) (AA marker) were quantified in the 87 
CM. For this purpose, Human Duo-set enzyme-linked immunosorbent assay (ELISA) kits (R&D 88 
Systems, Abingdon, UK) were used according to the manufacturer’s instructions.  89 
 90 
Trophoblast Cell Line culture 91 
SGHPL-4 cells were derived from primary human first trimester trophoblast and have been used 92 
extensively as a model for EVT (25, 26). SGHPL-4 cells express HLA-G and have been shown to 93 
respond in a manner similar to primary EVT (Cartwright et al 2002, Harris et al 2006). SGHPL-4 cells 94 
were cultured in Hams F10 media supplemented with 2mM L-glutamine, 100 units/ml penicillin, 95 
0.1mg/ml streptomycin and 10% (v/v) FBS (SGHPL-4 medium). 96 
 97 
SGHPL-4 Survival, Proliferation and Motility Assay 98 
To determine whether macrophage polarisation impacts on EVT behaviour, SGHPL-4 cells were 99 
treated with polarised THP-1 CM and assessed using time-lapse microscopy. The SGHPL-4 cells were 100 
serum-starved overnight (SGHPL-4 medium containing 0.5% (v/v) FBS) prior to treatment with 101 
polarised THP-1 CM (1x104 cells/ml). An Olympus 1x70 inverted microscope (Olympus, Southend-on-102 
Sea, UK) with a Hamamatsu C4742-95 digital camera and motorised stage (Hamamatsu Protonics) 103 
and Image-Pro Plus software (MediaCybernetics, Version 4.5) was used to image two positions in 104 
each well every 15min for 48h. Forty cells from each treatment were chosen at random and tracked 105 
using Image-Pro Insight software. To determine apoptotic cell death, the time frame at which 106 
apoptotic morphology became apparent was recorded (a phase bright appearance followed by 107 
membrane blebs or blisters (27)). To determine cell proliferation, the time frame at which a cell 108 
divided was recorded. 109 
SGHPL-4 motility was assessed using Image-Pro Insight software to track the individual trajectory of 110 
20 cells chosen at random for each treatment. To explore a possible role for macrophage secreted 111 
TNF-α in regulating trophoblast motility, TNF-α was neutralised in the CM using 5µg/ml of Mouse 112 
Anti-Human TNF monoclonal antibody with mouse IgG1κ used as an isotype control (BD Pharmingen, 113 
Oxford). Previous studies have shown that Mouse Anti-Human TNF monoclonal antibody is capable 114 
of neutralising the bioactivity of TNF in CM when used as per the manufacturer’s instructions (28).  115 
 116 
SGHPL-4 Western Blot Analysis  117 
A western blot analysis was undertaken to assess whether SGHPL-4 treatment with THP-1 CM affects 118 
the levels of apoptotic marker cleaved caspase 3. SGHPL-4 cells were cultured in polarised THP-1 CM 119 
for 24h (1x105 cells/ml). After 24h the cell lysate was collected and a western blot analysis 120 
performed, using 1:1000 rabbit anti-cleaved caspase 3 (Cell Signaling, UK) and 1:10000 mouse anti-121 
α-tubulin (Abcam, Cambridge, UK). Western blots were scanned using an Odyssey Scanner and the 122 
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density of each band determined. Results are expressed as a ratio to the loading control within each 123 
sample.  124 
 125 
 126 
SGHPL-4 Network-Formation Assay  127 
As EVT invade towards uterine spiral arteries, they alter their phenotype to become more 128 
endothelial-like (29). This can be modelled by assessing the ability of SGHPL-4 to form endothelial-129 
like network structures (30). The effect of the polarised THP-1 CM on the ability of SGHPL-4 cells to 130 
form endothelial-like networks on MatrigelTM (BD, Oxford, UK) was assessed using a μ-slide 131 
Angiogenesis Assay (Ibidi, Planegg, Germany) according to the manufacturer’s instructions. Images 132 
were captured as above, and network formation was assessed by measuring the average branch 133 
length and counting the total number of individual branches using Image-Pro Insight software. 134 
 135 
Statistics  136 
Statistical analysis was carried out using GraphPad Prism (Version 6.01). Paired T-tests or repeated 137 
measures one-way ANOVAs with post-test multiple comparisons were carried out as stated and 138 
statistical significance was assumed at p<0.05. 139 
 140 
RESULTS 141 
THP-1 cells can be polarised to reflect an CA or AA phenotype 142 
To confirm THP-1 polarisation, secretion of pro- and anti-inflammatory cytokines by the CA and AA- 143 
polarised THP-1 cells was assessed by ELISA (Figure 1). The CA CM had a significantly higher 144 
concentration of the pro-inflammatory cytokines IL-6 and TNF-α than the AA cells (p<0.05). The CA 145 
CM contained approximately 60-fold more IL-6 than the AA CM, where levels were only just within 146 
the assay detection limit. TNF-α production was over two-fold higher in the CA CM than the AA CM. 147 
Conversely, the AA CM contained approximately 5-fold more of the anti-inflammatory cytokine TGF-148 
β (p<0.001) than the CA CM.  149 
 150 
CA macrophages reduce SGHPL-4 motility 151 
SGHPL-4 motility in response to the polarised THP-1 CM was assessed by tracking individual SGHPL-4 152 
cells over 48h (Figure 2). Cells treated with the CA CM had significantly lower cell motility when 153 
compared to the media control and the AA CM (p<0.01 and p<0.01, respectively). Motility was 154 
unaffected by the AA CM when compared with the control. In order to assess whether TNF-α 155 
secretion was responsible for the differential effect of the CA and AA CM on the motility of the 156 
trophoblast cell line, TNF-α was blocked from the CM but this had no effect when compared to the 157 
control IgG1κ.  158 
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Both CA and AA macrophages inhibit SGHPL-4 proliferation 159 
To determine whether THP-1 polarisation state altered SGHPL-4 proliferation, SGHPL-4 cells were 160 
monitored by time-lapse microscopy following treatment with CA and AA CM. Treatment with both 161 
CA and AA CM almost completely abolished SGHPL-4 cell proliferation compared with the control 162 
(p<0.001) (Figure 3A, B), with an average of 49.5% of the SGHPL-4 cells proliferating in the control 163 
compared with 5.5 and 6% of the SGHPL-4 proliferating in the CA and AA CM, respectively.  164 
 165 
Secreted factors from CA polarised macrophages induce SGHPL-4 apoptosis 166 
Trophoblast apoptosis in response to polarised THP-1 CM was assessed by culturing SGHPL-4 cells 167 
with CA or AA CM and monitoring morphological changes by time-lapse microscopy. A significant 168 
difference in trophoblast apoptosis was not observed with either treatment (p>0.05) (Figure 3C, D). 169 
However, upon visual inspection morphological differences were consistently observed between the 170 
CA and AA treatments. Consequently, a western blot for the apoptotic protein cleaved PARP was 171 
undertaken. The CA CM was found to significantly increase the levels of cleaved caspase 3 in SGHPL-172 
4 cells, over that of the control and the AA CM (p<0.05) (Figure 4).   173 
 174 
AA macrophages are more able to promote SGHPL-4 network-formation than CA macrophages 175 
The ability of SGHPL-4 to form endothelial-like networks in response to polarised THP-1 CM was 176 
assessed. The AA CM promoted the formation of long tube-like structures that appeared to contain 177 
many trophoblast cells, whereas the CA CM resulted in the formation of significantly shorter tube-178 
like structures containing fewer cells (p<0.05). Branching of the tube-like structures was observed 179 
with both the CA and AA CM, although branching was more frequent with the CA CM resulting in the 180 
formation of shorter but more numerous and branching tube-like structures (p<0.01), and a network 181 
resembling a fine mesh of cells with a total length significantly higher than that of the control or AA 182 
treatment (p<0.001). No, or very few, tube-like structures were observed when SGHPL-4 were 183 
culture in the absence of THP-1 CM (Figure 5).  184 
 185 
 186 
DISCUSSION 187 
Impaired trophoblast invasion and spiral artery remodelling are associated with complications of 188 
pregnancy such as pre-eclampsia. The aim of this study was to determine whether the polarisation 189 
status of macrophages can impact upon trophoblast behaviour in-vitro. This was achieved by 190 
activating and polarising the human leukemic cell line THP-1 to reflect either a mature CA or AA 191 
macrophage phenotype and treating a trophoblast cell line with conditioned media (CM) from these 192 
cells.  The results of this study suggest that macrophages can alter the behaviour of trophoblast cells 193 
in-vitro and that this behaviour may be differentially affected by polarisation state. 194 
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The mechanisms involved in the regulation of trophoblast invasion and survival are poorly 195 
understood.  However, when these important functions are impaired, inadequate placentation and 196 
remodelling of spiral arteries can occur and are implicated in complications of pregnancy such as 197 
pre-eclampsia (4-6). An inverse relationship between reduced trophoblast invasion and macrophage 198 
infiltration of the spiral arteries has been reported in pre-eclampsia (14, 21), however, the 199 
polarisation status of these macrophages was unknown. In this study, when we exposed a 200 
trophoblast cell line to CA CM a significant inhibition of motility was observed when compared to the 201 
AA CM or control medium. This suggests that decidual macrophage polarisation towards a more pro-202 
inflammatory phenotype may contribute to impaired migration of trophoblast impacting on their 203 
ability to interact with cells of the spiral artery.  204 
Macrophages are primary producers of TNF-α, a pro-inflammatory cytokine belonging to a 205 
superfamily of soluble TNF ligands with diverse functionality (31). TNF-α is known to have a role in 206 
cellular apoptosis, proliferation, and motility (32) and is implicated in the pathology of pre-207 
eclampsia. For example, studies have shown that serum concentrations of TNF-α are significantly 208 
elevated in women with pre-eclampsia compared to normotensive controls (33). Furthermore, TNF-209 
α has previously been shown to inhibit EVT migration and invasion as a result of plasminogen 210 
activator inhibitor (PAI)-1 induction (18, 34). Therefore, we investigated whether TNF-α was the 211 
factor responsible for the differential effect of the CA and AA CM on EVT motility. However, blocking 212 
TNF-α was not found to alter the CA effect suggesting that additional mechanisms may influence 213 
trophoblast motility in response to macrophage polarisation.   214 
Decidual macrophages secrete a plethora of additional soluble factors some of which are known to 215 
influence trophoblast invasion and migration. For example, they are known to secrete vascular 216 
endothelial growth factor (VEGF) and IL-10 both of which are thought to have an inhibitory effect on 217 
trophoblast motility (35, 36). They also produce a number of soluble factors that have been shown 218 
to promote trophoblast motility such as IL-1β and IL-8 (37, 38). It is likely that a combination of 219 
inhibitory and promotional factors is responsible for macrophage regulation of trophoblast motility, 220 
and it is possible that the balance is tipped towards inhibition with CA polarisation.  221 
Apoptosis is an important mechanism in normal placental development and decidual remodelling, 222 
although excessive apoptosis may play a role in the pathology of pre-eclampsia (39). When we 223 
investigated the effect of macrophage polarisation on EVT apoptosis by time-lapse microscopy no 224 
significant difference above basal levels was observed with either the CA or AA treatment. However, 225 
differences in SGHPL-4 morphology between the treatments were observed. When SGHPL-4 protein 226 
levels of cleaved caspase 3 were investigated, the CA treatment was found to significantly up-227 
regulate this apoptotic marker. It is likely that these results reflect the stage at which apoptosis was 228 
assessed; caspase 3 is an intracellular protein with a central role in the apoptotic cascade whereas 229 
morphological analysis of membrane integrity through time-lapse assesses the terminal stage of 230 
apoptosis. This observation correlates with previous studies that have shown an association 231 
between the number of activated macrophages and apoptosis in other EVT cell lines (40).  232 
During the first trimester of pregnancy, EVT migrate in columns from the placental villi into the 233 
decidua. EVT at the tips of these columns subsequently detach and differentiate to become either 234 
interstitial or endovascular trophoblast which, as they differentiate, exit the cell cycle and cease 235 
proliferating (41, 42). In our study treatment with both the CA and AA CM was found to abolish 236 
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SGHPL-4 proliferation. Given these observations, it is possible that macrophages within the decidua 237 
are capable of influencing EVT differentiation towards a less proliferative, more invasive, 238 
endovascular phenotype, irrespective of macrophage phenotype.  It will be important to confirm this 239 
with isolated primary first trimester trophoblast cells. 240 
Spiral artery remodelling occurs during the first half of human pregnancy and results in replacement 241 
of the endothelium and vascular smooth muscle cells by invasive endovascular EVT (41). This 242 
requires endovascular EVT to adopt a vascular phenotype (29) and SGHPL-4 cells have previously 243 
been shown to form tube-like networks when seeded on MatrigelTM (30, 43). Decidual macrophages 244 
secrete a range of angiogenic growth factors including angiogenin, keratinocyte growth factor, 245 
fibroblast growth factor B, vascular endothelial growth factor A, and angiopoietin-1 and -2 (44). Both 246 
the CA and AA macrophage CMs were found to induce network formation however the AA CM 247 
induced formation of significantly longer tube-like structures comprised of many cells in close 248 
contact, whereas the CA CM produced shorter, branching structures, which were morphologically 249 
less organised and contained fewer cells. AA macrophages have been shown to express fewer angio-250 
inhibitory cytokines than classically activated MØ (45). Our results may reflect a requirement for 251 
tissue remodelling AA-like decidual macrophages during the co-ordinated changes to spiral arteries, 252 
and suggests that the presence of inflammatory CA-like decidual macrophages may lead to 253 
inefficient remodelling.  254 
By using THP-1 cells to model the extremes of macrophage polarisation we have clearly shown that 255 
macrophage phenotype can affect trophoblast behaviour. THP-1 cells are widely used to model 256 
human monocytes and macrophages, and have been well characterised (46). PMA is commonly used 257 
to activate THP-1 cells (47-49) and LPS and IFN-γ, and IL-13 and IL-4, frequently used to generate CA- 258 
and AA-like cells, respectively, in order to mimic the extremes of macrophage polarisation (24, 50, 259 
51). In future studies it would be interesting to determine the effect of different stimulatory 260 
conditions on primary decidual macrophages and their interactions with trophoblast.  261 
 262 
In-vivo, it is unlikely that decidual macrophages can be defined as either CA or AA with increasing 263 
evidence that they have a unique phenotype. For instance, gene expression profiling has 264 
demonstrated that first trimester decidual macrophages resemble AA macrophages when compared 265 
to peripheral blood CD14+ monocytes, with up-regulation of genes implicated in immune modulation 266 
and tissue remodelling, but also upregulate genes corresponding to an CA phenotype (15). 267 
Furthermore, it is possible that there are different macrophage populations within the decidua, in 268 
response to the local microenvironment. For example, two distinct subsets of CD14+ decidual 269 
macrophages have been characterised by their level of CD11c expression (19) and intercellular 270 
adhesion molecule 3 (ICAM-3) expression (20). Therefore, in future studies it will be important to 271 
investigate whether decidual macrophage activation is location-specific and to determine how this 272 
contributes to the regulation of neighbouring cells, in addition to addressing whether this is different 273 
in pre-eclamptic pregnancies.  274 
 275 
Although further in-vivo studies are required, our study demonstrates that macrophage polarisation 276 
can affect the behaviour of a trophoblast cell line in-vitro and is likely to have an important role in 277 
the regulation of placental development. Furthermore, macrophage polarisation towards a more 278 
pro-inflammatory phenotype may be one of the mechanisms responsible for the shallow 279 
placentation and impaired spiral artery remodelling observed in pre-eclampsia. 280 
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Figure 1. Quantification of IL-6, TNF-α and TGF-β1 in the CM of THP-1 cells exposed to PMA and 1 
polarising factors. THP-1 cells (4x10
6
) were activated in 6ml of THP-1 medium with 100nM PMA and 2 
classically or alternatively activated with 100ng/ml of LPS and 20ng/ml of IFN-γ or 20ng/ml of IL-4 3 
and 20ng/ml of IL-13, respectively. After 72h the polarising media was replaced with fresh THP-1 4 
medium without polarising factors. The CM was collected after 24h and the concentration of IL-6, 5 
TNF-α and TGF-β assessed by ELISA and the treatments compared statistically using a paired T-test. 6 
A) The concentration of IL-6 (pg/ml), n=9, *p<0.05. B) The concentration of TNF-α (pg/ml), n=9, 7 
*p<0.05. C) The concentration of TGF-β1 (pg/ml), n=6, ***p<0.001. Data is presented as mean + 8 
SEM. 9 
 10 
Figure 2. SGHPL-4 motility when treated with polarised THP-1 CM. SGHPL-4 cells (1x10
4
/ml) were 11 
serum-starved with SGHPL-4 medium containing 0.5% (v/v) FBS for 18h and subsequently treated 12 
with 1ml of CA or AA CM, or THP-1 medium as a control. The cells were imaged using time-lapse 13 
microscopy for 48h. Motility is presented as an average of 20 cells per treatment in arbitrary units. 14 
The treatments were compared statistically using a repeated measures ANOVA and Tukey’s multiple 15 
comparisons test. A) CA CM significantly decreased the motility of trophoblast, n=5 experimental 16 
repeats, **p<0.01. B) THP-1 CM was treated with a neutralising antibody against TNF-α (anti-TNF) or 17 
a control IgG1κ. TNF-a neutralisation had no effect on trophoblast motility, n=4 experimental 18 
repeats, *p<0.05.  Data is presented as mean + SEM. 19 
 20 
Figure 3. SGHPL-4 proliferation and cell death when treated with polarised THP-1 CM. SGHPL-4 21 
cells (1x10
4
/ml) were serum-starved with SGHPL-1 medium for 18h and subsequently treated with 22 
1ml of CA or AA CM, or THP-1 medium as a control. The cells were imaged using time-lapse 23 
microscopy for 48h and cell morphology observed for division or apoptotic changes. The treatments 24 
were compared statistically using a repeated measures ANOVA and Tukey’s multiple comparisons 25 
test, n=5 experimental repeats. A) A significant difference in proliferation was found between the 26 
treatments and the control, ***p<0.001. B) Proliferation over time. C) No significant differences in 27 
apoptosis were found between the treatments, p>0.05. D) Apoptosis over time. Data is presented as 28 
mean + SEM. 29 
 30 
Figure 4. SGHPL-4 expression of cleaved caspase 3 (17kDa) when treated with polarised THP-1 CM.  31 
SGHPL-4 cells were incubated with CA CM, AA CM or control media for 24h, total protein collected, 32 
and western blot analysis of cleaved caspase 3 undertaken. The treatments were compared 33 
statistically using a repeated measures ANOVA and Tukey’s multiple comparisons test, n=6 34 
experimental repeats. A) Representative western blot analysis of cleaved caspase 3 and tubulin. B) 35 
SGHPL-4 cell incubation with CA CM significantly upregulates expression of cleaved caspase 3 36 
(17kDa) when compared with AA CM or THP-1 control medium, **p<0.01. Data is presented as 37 
mean + SEM. C) Representative morphology of SGHPL-4 cells treated with CA CM, AA CM or control 38 
media. Original magnification: 10X. 39 
 40 
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Figure 5. SGHPL-4  endothelial-like network formation when treated with polarised THP-1 CM. 41 
SGHPL-4 cells were cultured on Matrigel
TM
 in the presence of polarised THP-1 CM, or THP-1 medium 42 
as a control, to induce endothelial-like network formation, and imaged after 24h. The treatments 43 
were compared statistically using a repeated measures ANOVA and Tukey’s multiple comparisons 44 
test, n=4 experimental repeats. A) The total number of branches was significantly increased in the 45 
CA CM compared with the AA CM and control (**p<0.01). B) The average length of branch structures 46 
was significantly increased in response to the AA CM when compared with the CA CM and the 47 
control (**p<0.01). Original magnification: 4X. Data is presented as mean + SEM.  48 
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Highlights  
 
• Extravillous trophoblast motility is inhibited by classically activated macrophages.  
• Alternatively activated macrophages support trophoblast network-formation.  
• Macrophage polarisation can affect important trophoblast functions.  
• Alterations in macrophage phenotype may impair trophoblast decidual remodelling. 
